Skip to content

C Frank Bennett, EVP, Chief Scientific Officer at Ionis Pharmaceuticals, sold IONS on Jul 7, 2026

Data as of Oct 16

▼ SELL$463K5,536 shares at $83.58C Frank Bennett EVP, Chief Scientific OfficerIONS Ionis Pharmaceuticals Inc
Watch IONS
Traded
Jul 7, 2026
Disclosed
Jul 9, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

C Frank Bennett, EVP, Chief Scientific Officer at Ionis Pharmaceuticals, sold IONS on Jul 7, 2026TRADEDDISCLOSED
IONSSimilar stocks (XLV — its sector index fund), rebased to IONS's price on the disclosure day
IONS since disclosure
−33.2%
after the sale
Similar stocks (XLV) since disclosure
+9.0%
XLV — its sector index fund

Change in closing price from Jul 9, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLC Frank Bennett EVP, Chief Scientific OfficerIONS Ionis Pharmaceuticals Inc$1.3Mdisclosed Jul 9 · filed 2 days after the trade

See every trade on IONS →